CAN-R Site Map

Surveillance of Pathogens and Infections

• Canadian Antifungal Susceptibility Trials
• Canadian Intensive Care Unit Study [CAN-ICU]
• Study Overview and Methodology
• National Infection Data
• Regional Infection Data
• Susceptibility Data
• National
• Regional
• Quality Management Program - Laboratory Services [QMPLS] MRSA & VRE Data
• Canadian Respiratory Organism Susceptibility Study (CROSS Study)
• H. influenzae
• % β-lactamase +ve H. influenzae
• Annual H. influenzae (ß-lactamase +ve) susceptibility per province
• M. catarrhalis
• M. catarrhalis Susceptibility
• Penicillin-Resistant S. pneumoniae
• Canada All Patients
• % Distribution
• Prevalence
• Provincial Prevalence
• Macrolide Resistant S. pneumoniae
• Macrolide use/Macrolide Resistant S. pneumoniae
• Prevalence
• % Distribution of S. pneumoniae Macrolide MICs
• Non-susceptible Bacteremic vs. Respiratory Isolates of S. pneumoniae
• Non-susceptible Bacteremic vs. Respiratory Isolates of S. pneumoniae
• Fluoroquinolone Resistant S. pneumoniae
• In vitro Activity of Fluoroquinolones Against Ciprofloxacin-Resistant S. pneumoniae
• % Distribution of Fluoroquinolone MICs in S. pneumoniae
• Fluoroquinolone Resistance vs S. Pneumoniae
• Fluoroquinolone MICs in Canada
• Macrolide Resistant S. pneumoniae
• Macrolide R S. pneumoniae Genotyping
• Macrolide MIC Distribution versus S. pneumoniae
• Macrolide R S. pneumoniae Genotyping N (%)
• Activity of Antimicrobials vs. Macrolide Resistant SPN Genotypes
• Macrolide-Susceptible S. pneumoniae All Patients
• S. pyogenes (macrolide susceptible)
• Annual S. pyogenes (macrolide susceptible) susceptibility per province
• NAUTICA Data
• Demographics
• Isolation of outpatient urinary isolates (n=1990) by age and gender
• Isolation of outpatient urinary isolates of E. coli (n=1142) by age and gender
• Bacteriology of 1990 outpatient urinary isolates
• Antibiotic Resistance
• Antibiotic resistance in all 1990 outpatient isolates
• Antibiotic resistance in E. coli (n=1142) outpatient isolates
• MIC Distributions
• MIC distributions for all 1990 outpatient isolates
• MIC distributions for 1142 E. coli outpatient isolates
• Canadian Regional Antibiotic Resistance Breakdown
• Antibiotic resistance in all 1990 outpatient isolates in participating Canadian provinces
• Antibiotic resistance in E. coli outpatient isolates in participating Canadian provinces

Antimicrobial Usage

• Canadian Antibiotic Usage
• Provincial
• National/International
• Antibiotics under WHO ATC Classification

Investigational Antimicrobials

• API-1252
• ICAAC 2006 API-1252
• ICAAC 2006 API-1252
• ICAAC 2006 API-1252
• Daptomycin
• ICAAC 2006 Daptomycin Posters
• IDSA 2006 Daptomycin Posters

Recent Research

• Azole Antifungals
• Azole Resistance in Bacteremic Candida species: Canada 1998-2005
• Tigecycline
• CAN-ICU Tigecycline Poster For AMMI 2006
• Activity of Tigecycline Against 4180 Pathogens Obtained From Canadian Intensive Care Units: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study
• Pharmacodynamic (PD) Activity of Tigecycline vs. Molecularly Characterized Multi-Drug Resistant (MDR) Extended Spectrum β-Lactamase (ESBL) Producing E. coli Using an In Vitro Model
• Various Inpatient Antimicrobials
• Influence of Geographic Region, Gender and Age on Antimicrobial Resistance Patterns of Pathogens from Canadian Intensive Care Units (ICUs)
• Characterization of MRSA, VRE and ESBL Isolated from Canadian Intensive Care Units: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study
• Various Outpatient Antimicrobials
• Antibiotic Resistant S. pneumoniae and Antibiotic Use In Canada From 1995-2005
• Changes in Antibiotic Prescribing Among Physician Specialties in Canada From 1996-2005

CAN-R Hot Topics

• June 2007, by Dr. Grant Stiver
• Some help with resistant Gram positive infections?
• Fluoroquinolone Resistant Gonorrhea
• Fluoroquinolone Resistance in Urinary Tract Infections: How can it be reduced?
• March/April 2007, by Dr. Susan Poutanen
• Rapid Influenza Testing Leads to Reductions in Antimicrobial Use in Hospitalized Adults – Let’s Get Testing!
• Canadian Guidelines for the Prevention and Management of Community-associated MRSA Have Been Published
• A Review of Antimicrobial Resistance Resources on the Web
• September 2006, by Dr. Susan Poutanen
• Almost 80% of Community-Acquired S. aureus Skin and Soft Tissue Infections are due to MRSA in the US - Only a Matter of Time for Canada?
• Small Colony Variant VRE Continue to be Isolated in Ontario, Canada.
• Survival of the Fittest Antimicrobial Resistant Determinant

Mechanisms in Resistance

• Beta-lactams
• Fluoroquinolones
• Macrolides

Practice Guidelines

• IDSA/ATS Guidelines on the Management of Community-Acquired Pneumonia
• Guidelines for the Prevention and Management of Community-associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA): A Perspective for Canadian Health Care Practitioners
• Highlights of IDSA Complicated Intra-abdominal Infection Guidelines

Media / Public

• Press releases
• CAN-ICU Press Release
• Tygacil Availability Press Release
• Backgrounders
• Antibiotic Resistance in Canada backgrounder
• CAN-ICU backgrounder
• IAI/SSI Infections backgrounder
• Tygacil backgrounder
• Clostridium difficile-Associated Diarrhea
• Extended-spectrum Beta-lactamase Resistance
• Vancomycin Resistant Staphylococcus aureus (VRSA)
• Methicillin Resistant Staphylococcus aureus (MRSA)
• Vancomycin Resistant Enterococci (VRE)
• Other resourses
• Media Guide on Antibiotic Resistance
• Antibiotic Resistance in Canada Map
• Media launch at AMMI conference 2007
• CAN-R in the News
• CAN-R Press Release
• CAN-R Backgrounder
• CAN-R Website Media Preview (webcast)

Antimicrobial Stewardship and Infection Control